...
机译:颈椎癌后宫颈切除术治疗癌或癌原位的预测因子
Department of Obstetrics and Gynecology Division of Gynecologic Oncology NorthShore University;
Department of Pathology and Laboratory Medicine Olive View-UCLA Medical Center Sylmar CA United;
Department of Obstetrics and Gynecology Harbor-UCLA Medical Center Los Angeles CA United States;
Department of Obstetrics and Gynecology Olive View-UCLA Medical Center Sylmar CA United States;
Department of Pathology and Laboratory Medicine Cedars-Sinai Medical Center Los Angeles CA;
Department of Obstetrics and Gynecology Division of Gynecologic Oncology Olive View-UCLA Medical;
Department of Obstetrics and Gynecology Division of Gynecologic Oncology Cedars-Sinai Medical;
Cervical carcinoma in-situ; Microinvasive cervical cancer; Positive endocervical curettage; Positive margins; Residual disease;
机译:宫颈锥切后切缘阳性的子宫切除术后残留癌或原位癌的预测因子
机译:对于HSIL或微浸润性宫颈癌具有阳性手术切缘的宫颈锥切术后,是否存在任何残留疾病的预测指标?
机译:宫颈上皮内瘤变为2和3级且手术切缘阳性的患者在宫颈锥切术后残留疾病的危险因素
机译:Escin在小鼠宫颈癌U_(14)和人宫颈癌Hela细胞系中的抗肿瘤活性
机译:喀麦隆HIV阳性妇女的宫颈癌前病变:筛查的患病率,预测因素和潜在影响。
机译:高位子宫颈上皮内瘤变及初次锥切术后切缘阳性的残留疾病和危险因素
机译:脊髓癌癌原位术后阳性阴道细胞学复发(三种情况)